country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-156484

Copy Link Print Information

SPR519

SPR519 is a selective, orally active dual PI3Kα/mTOR kinase inhibitor, with an IC₅₀ of 0.03 μM against PI3Kα and an IC₅₀ of 0.01 μM against mTOR. SPR519 exhibits anticancer effects in ovarian cancer and colon cancer xenograft models. SPR519 can be used for the research of solid tumors (ovarian cancer, colon cancer).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 1391923-59-3
Formel: C₁₉H₂₁N₇O₃S
Molecular Weight:427.48

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

SPR519 Chemical Structure

CAS. Nr.: 1391923-59-3

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- Parmacokinetics
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target^[1]

PI3Kα

0.03 μM (IC₅₀)

mTOR

0.01 μM (IC₅₀)

Alle PI3K Isoform-spezifische Produkte anzeigen :

Alle mTOR Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
A2780	IC₅₀	0.23 μM Compound: 10; SPR519	Antiproliferative activity against human A2780 cells after 48 hrs by MTT assay Antiproliferative activity against human A2780 cells after 48 hrs by MTT assay	[PMID: 32897703]
PC-3	EC₅₀	0.48 μM Compound: 10; SPR519	Antiproliferative activity against human PC-3 cells after 48 hrs by MTT assay Antiproliferative activity against human PC-3 cells after 48 hrs by MTT assay	[PMID: 32897703]
SK-OV-3	EC₅₀	0.5 μM Compound: 10; SPR519	Antiproliferative activity against human SK-OV-3 cells after 48 hrs by MTT assay Antiproliferative activity against human SK-OV-3 cells after 48 hrs by MTT assay	[PMID: 32897703]

In Vitro

SPR519 (0.001-10 µM; 15 min) inhibits purified PI3Kα enzyme with an IC₅₀ of 0.03 µM^[1].
SPR519 inhibits purified mTOR enzyme with an IC₅₀ of 0.01 µM^[1].
SPR519 (0.001-20 µM; 48 h) inhibits A2780 human ovarian cancer cell proliferation with an EC₅₀ of 0.23 µM^[1].
SPR519 (0.001-20 µM; 48 h) inhibits PC3 human prostate cancer cell proliferation with an EC₅₀ of 0.48 µM^[1].
SPR519 (0.001-20 µM; 48 h) inhibits SKOV3 human ovarian cancer cell proliferation with an EC₅₀ of 0.50 µM^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:

A2780 human ovarian cancer cells
Concentration:

0.001-20 µM
Incubation Time:

48 h
Result:

Inhibited A2780 cell proliferation with an EC₅₀ of 0.23 µM.

Cell Proliferation Assay^[1]

Cell Line:

PC3 human prostate cancer cells
Concentration:

0.001-20 µM
Incubation Time:

48 h
Result:

Inhibited PC3 cell proliferation with an EC₅₀ of 0.48 µM.

Cell Proliferation Assay^[1]

Cell Line:

SKOV3 human ovarian cancer cells
Concentration:

0.001-20 µM
Incubation Time:

48 h
Result:

Inhibited SKOV3 cell proliferation with an EC₅₀ of 0.50 µM.

Parmacokinetics

Species	Dose	Route	AUC	C_max	T_max	T_1/2
Mice^[1]	1 mg/kg	p.o.	26858 nM·h	5014 nM	1.33 h	2.66 h
Mice^[1]	3 mg/kg	p.o.	32146 nM·h	6903 nM	1.50 h	2.74 h
Mice^[1]	10 mg/kg	p.o.	76365 nM·h	12558 nM	1.67 h	2.52 h

In Vivo

SPR519 (2.5-10 mg/kg; p.o.; once daily; for 27 consecutive days) exerts significant, dose-dependent tumor growth inhibition in female CD1 nude mice bearing SKOV-3 ovarian cancer xenografts, even at the low dose of 2.5 mg/kg administered orally once daily for 27 consecutive days^[1].
SPR519 (2.5-20 mg/kg; p.o.; once daily; for 21 consecutive days) exerts significant, dose-dependent tumor growth inhibition in female CD1 nude mice bearing HCT116 colon cancer xenografts^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

CD1 nude mice (female; subcutaneous SKOV-3 ovarian cancer xenografts, tumors grown to 120-130 mm³ before treatment)^[1]
Dosage:

2.5 mg/kg; 5 mg/kg; 10 mg/kg
Administration:

p.o.; once daily; 27 days
Result:

Induced considerable dose-dependent tumor growth inhibition starting 3 days after treatment initiation across all doses.
Reduced tumor volume.

Animal Model:

CD1 nude mice (female; subcutaneous HCT116 colon cancer xenografts, tumors grown to 120-130 mm³ before treatment)^[1]
Dosage:

2.5 mg/kg; 5 mg/kg; 10 mg/kg; 20 mg/kg
Administration:

p.o.; once daily; 21 days
Result:

Induced considerable dose-dependent tumor growth inhibition starting 3 days after treatment initiation across all doses.
Reduced tumor volume.

Chemical Information

CAS. Nr. 1391923-59-3
Molecular Weight 427.48
Formel C₁₉H₂₁N₇O₃S
SMILES

O=C(C1=CC=C(OC2=NC(=NC(=N2)N3CCOCC3)C=4SC(=NC4)N)C=C1)N(C)C
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Mahajan D, et al. Discovery and Development of SPR519 as a Potent, Selective, and Orally Bioavailable Inhibitor of PI3Kα and mTOR Kinases for the Treatment of Solid Tumors. J Med Chem. 2020;63(19):11121-11130. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

SPR519

Alle PI3K Isoform-spezifische Produkte anzeigen

Alle mTOR Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Reinheit & Dokumentation

Verweise

Calculators

Help & FAQs

SPR519 Related Classifications

HY-156484 Related Classifications